Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Mivi Neuroscience
AddedFeb 15, 2024
UpdatedJun 18, 2026
Mivi Neuroscience

Mivi Neuroscience

Series B

MIVI Neuroscience: Innovating stroke treatment with proprietary medical device technology.

HQ
Eden Prairie, MN, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize stroke treatment, MIVI Neuroscience is an innovative medical device company dedicated to improving outcomes for patients experiencing acute ischemic stroke (AIS). Leveraging proprietary technology developed in collaboration with physicians, MIVI aims to equip healthcare providers with advanced tools to enhance stroke care. Their product line includes the Q™ Aspiration Catheter and the Q™ Distal Access Catheter, designed to facilitate more effective and efficient stroke interventions.

MIVI Neuroscience has garnered attention from notable investors and industry leaders, contributing to its rapid growth and impact in the medical field. The company's achievements include significant advancements in stroke treatment technology and successful clinical outcomes, positioning it as a key player in the neurovascular market. Through its relentless pursuit of innovation, MIVI is expanding the possibilities in stroke treatment, ultimately aiming to save lives and improve patient recovery rates.

Mivi Neuroscience - Similar Companies

Progressive Nuero logo

Progressive Nuero

Cognition Medical logo

Cognition Medical

NeuRx Medical logo

NeuRx Medical

neurxmed.com

NeuroVasx logo

NeuroVasx

NeuroVasc Technologies logo

NeuroVasc Technologies

StrokeDx logo

StrokeDx

stroke-dx.com

Rapidpulse logo

Rapidpulse

rapidpulsemed.com

Epic Neuro logo

Epic Neuro

CereVasc logo

CereVasc

cerevasc.com

Neuro42 logo

Neuro42

Q'Apel Medical logo

Q'Apel Medical

qapelmedical.com

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

MindRhythm logo

MindRhythm

mindrhythm.com

Nervive logo

Nervive

CranioVation logo

CranioVation

craniovation.com

Mivi Neuroscience - Quick Facts

Who are Mivi Neuroscience's competitors?

Companies similar to Mivi Neuroscience include Progressive Nuero, Cognition Medical, NeuRx Medical and NeuroVasx.

When was Mivi Neuroscience founded?

Mivi Neuroscience was founded in 2013.

Where is Mivi Neuroscience's headquarters located?

Mivi Neuroscience's headquarters is located in Eden Prairie, MN, US.

When was Mivi Neuroscience's last funding round?

Mivi Neuroscience's most recent funding round was for $35M (USD) in January 2021.

How much has Mivi Neuroscience raised to-date?

As of Jan 21, 2021, Mivi Neuroscience has raised a total of $92.3M (USD).

How many employees does Mivi Neuroscience have?

Mivi Neuroscience has 42 employees as of Feb 5, 2024.

Mivi Neuroscience - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified